DE69231232T2 - Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür - Google Patents

Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür

Info

Publication number
DE69231232T2
DE69231232T2 DE69231232T DE69231232T DE69231232T2 DE 69231232 T2 DE69231232 T2 DE 69231232T2 DE 69231232 T DE69231232 T DE 69231232T DE 69231232 T DE69231232 T DE 69231232T DE 69231232 T2 DE69231232 T2 DE 69231232T2
Authority
DE
Germany
Prior art keywords
lmrh
immunoneutralizing
peptides
therefor
castrated male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69231232T
Other languages
English (en)
Other versions
DE69231232D1 (de
Inventor
Raymond Dufour
Claude Roulet
Claire Chouvet
Michel Bernard Bonneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26228546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69231232(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9102513A external-priority patent/FR2673377B1/fr
Priority claimed from FR9115289A external-priority patent/FR2685333B1/fr
Application filed by Merial SAS filed Critical Merial SAS
Application granted granted Critical
Publication of DE69231232D1 publication Critical patent/DE69231232D1/de
Publication of DE69231232T2 publication Critical patent/DE69231232T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
DE69231232T 1991-03-01 1992-02-26 Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür Expired - Lifetime DE69231232T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9102513A FR2673377B1 (fr) 1991-03-01 1991-03-01 Procede pour ameliorer les qualites organoleptiques des animaux domestiques non castres.
FR9115289A FR2685333B1 (fr) 1991-12-10 1991-12-10 Nouveau peptide notamment pour la realisation de conjugues immunogenes anti-lhrh, vaccins les incorporant et ensemble de vaccination y relatif.

Publications (2)

Publication Number Publication Date
DE69231232D1 DE69231232D1 (de) 2000-08-17
DE69231232T2 true DE69231232T2 (de) 2001-01-04

Family

ID=26228546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231232T Expired - Lifetime DE69231232T2 (de) 1991-03-01 1992-02-26 Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür

Country Status (19)

Country Link
US (1) US5573767A (de)
EP (1) EP0501882B1 (de)
JP (1) JP3177246B2 (de)
KR (1) KR100257214B1 (de)
AT (1) ATE194625T1 (de)
CA (1) CA2081660C (de)
CZ (1) CZ287775B6 (de)
DE (1) DE69231232T2 (de)
DK (1) DK0501882T3 (de)
ES (1) ES2149166T3 (de)
GR (1) GR3034509T3 (de)
HU (1) HU214453B (de)
IE (1) IE920648A1 (de)
PL (1) PL296623A1 (de)
PT (1) PT501882E (de)
SK (1) SK282056B6 (de)
TW (1) TW221674B (de)
UA (1) UA40570C2 (de)
WO (1) WO1992015330A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6761890B1 (en) * 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
CU22627A1 (es) * 1996-12-17 2000-12-22 Ct Ingenieria Genetica Biotech Preparado vacunal para la inmuno-castración reversible de mamíferos
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
AU770409B2 (en) * 1998-05-05 2004-02-19 Metamorphix International, Inc. Methods of raising animals for meat production
US6626871B1 (en) 1999-10-11 2003-09-30 Felton International, Inc. Method and apparatus for removing cap from medical device
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
AU2003262379A1 (en) * 2002-04-16 2003-11-03 Auburn University TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
SG173223A1 (en) 2003-04-22 2011-08-29 Ipsen Pharma Sas Peptide vectors
JP2005098877A (ja) * 2003-09-25 2005-04-14 Hitachi Software Eng Co Ltd 抗体検出体、その製造方法、及び抗体検出方法
NZ554332A (en) * 2004-09-10 2010-01-29 Queensland Inst Med Res Truncated LHRH formulations with T helper cell epitopes
CA2590337C (en) 2004-12-15 2017-07-11 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
KR100701550B1 (ko) * 2005-05-24 2007-03-30 한국과학기술연구원 베어링리스 스텝모터
WO2009017467A1 (en) 2007-07-27 2009-02-05 Elan Pharma International Limited Treatment of amyloidogenic diseases
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
JP5752343B2 (ja) * 2007-01-24 2015-07-22 株式会社ココカラファインネクスト Ｓ／ｏ型経皮免疫剤
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
CA2837375C (en) 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
EP2914714A4 (de) * 2012-10-30 2016-09-21 Recombinetics Inc Steuerung der geschlechtsreife bei tieren

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4018726A (en) * 1975-06-12 1977-04-19 Andrew Victor Schally [D-Phe6 ]-LH-RH and intermediates therefor
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4676981A (en) * 1984-02-07 1987-06-30 University Of Saskatchewan Monoclonal antibodies against GnRH
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
JPH01500663A (ja) * 1986-08-18 1989-03-09 バンジ・（オーストラリア）・プロプライアタリー・リミテッド 動物の生殖機能の調節
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
NL8900726A (nl) * 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
US5484592A (en) * 1989-03-23 1996-01-16 Stitching Centraal Diergeneeskundig Instituut Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs

Also Published As

Publication number Publication date
CZ287775B6 (cs) 2001-01-17
PT501882E (pt) 2000-12-29
ATE194625T1 (de) 2000-07-15
ES2149166T3 (es) 2000-11-01
EP0501882A3 (en) 1992-10-14
HUT63338A (en) 1993-08-30
EP0501882A2 (de) 1992-09-02
EP0501882B1 (de) 2000-07-12
UA40570C2 (uk) 2001-08-15
US5573767A (en) 1996-11-12
SK282056B6 (sk) 2001-10-08
DK0501882T3 (da) 2000-12-11
TW221674B (de) 1994-03-11
JP3177246B2 (ja) 2001-06-18
KR100257214B1 (ko) 2000-05-15
SK328092A3 (en) 1995-01-05
PL296623A1 (en) 1993-09-20
HU214453B (hu) 1998-03-30
DE69231232D1 (de) 2000-08-17
IE920648A1 (en) 1992-09-09
CA2081660A1 (en) 1992-09-02
WO1992015330A1 (fr) 1992-09-17
JPH05506459A (ja) 1993-09-22
CZ328092A3 (en) 1993-10-13
CA2081660C (en) 2001-05-01
GR3034509T3 (en) 2000-12-29
HU9203419D0 (en) 1993-01-28

Similar Documents

Publication Publication Date Title
DE69231232D1 (de) Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür
NO933126D0 (no) Loeselige ligander for cd40
KR937000146A (ko) 거세되지 않은 수컷 가축의 고기의 관능적 품질을 개선하기 위한 방법, 이 방법에 이용 가능한 백신, 특히 그 백신을 생산하기 위한 신규의 펩티드 및 그에 관계된 백신반응 키트
AU7814498A (en) Multivalent (in ovo) avian vaccine
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
MY104556A (en) Anoxic slaughtering of poultry
ATE185148T1 (de) Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine
DE3867119D1 (de) Verfahren zum betaeuben von lungenatmenden schlachttieren.
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
DE50201897D1 (de) Betäubungsbox für rinder und verfahren zum betäuben und töten von rindern
US7258870B2 (en) Poultry feed supplement for increasing poultry-based meat weight
MX9207129A (es) Metodo para mejorar las cualidades organolepticas de la carne de animales domesticos sin castrar, vacunas que son utilizables en este metodo, nuevo peptido, en particular, para producir esas vacunas, y estuche de vacunacion relacionado con ello.
TW368393B (en) Poison bait for controlling noxious insects
Wołos et al. Postnatal ontogenetic studies on kidney and liver carnosinase activity and carnosine content in muscles of turkey
ATE331030T1 (de) Verfahren zur expression von polypeptide in fishen durch wässerung in dns enthaltende lösung
CN1067551C (zh) 猪源抗鸡主要传染病高免血清的制备方法
NL9201430A (nl) Werkwijze en inrichting voor het verdoven van dieren.
DE59602588D1 (de) Vorrichtung zum elektrischen Betäuben von Schlachttieren
RU96107735A (ru) Способ подготовки туш свиней к длительному хранению
RO100738A2 (ro) Procedeu de preparare a vaccinului inactivat uleios, contra bursitei infectioase aviare
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
IT1260260B (it) Metodo di preparazione di un salume/arrosto pronto all'uso rispettivo salume/arrosto pronto all'uso cosi ottenuto
GB2306096A (en) The treatment of small animals
IT1254417B (it) Processo di fabbricazione di biochelati.

Legal Events

Date Code Title Description
8363 Opposition against the patent